RE: RE: RE: RE: RE: is anyone out there? Yep. Visualize vascular is a great product that should reward shareholders handsomely as it gains increasing implementation. Just hold steady and don't succumb to emotional pressure from bumps in the market. Selling this while you're down would be a short sighted rookie move IMO.